Frederick A. Brightbill
First SEC filing: July 21, 2020 · Latest: July 21, 2020
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 30, 2024 | MCFT | F | 11,197 | $18.88 | $211,399 | 230,449 Direct | -4.63% | Disposed | 4.9% (price as of 2026-10-05) |
| Sept. 5, 2023 | MCFT | A | 34,426 | · | · | 205,383 Direct | +20.14% | Acquired | (price as of 2026-10-05) |
| Sept. 5, 2023 | MCFT | A | 59,790 | · | · | 265,173 Direct | +29.11% | Acquired | (price as of 2026-10-05) |
| Sept. 5, 2023 | MCFT | A | 23,527 | · | · | 241,646 Direct | -8.87% | Disposed | (price as of 2026-10-05) |
| July 16, 2023 | MCFT | F | 3,451 | $28.14 | $97,111 | 170,957 Direct | -1.98% | Disposed | -29.6% (price as of 2026-10-05) |
| June 30, 2023 | MCFT | F | 6,682 | $30.65 | $204,803 | 174,408 Direct | -3.69% | Disposed | -35.4% (price as of 2026-10-05) |
| Sept. 10, 2022 | MCFT | F | 1,816 | $21.17 | $38,445 | 181,090 Direct | -0.99% | Disposed | -6.4% (price as of 2026-10-05) |
| Sept. 8, 2022 | MCFT | A | 24,658 | · | · | 190,143 Direct | +14.90% | Acquired | (price as of 2026-10-05) |
| Sept. 8, 2022 | MCFT | F | 7,237 | · | · | 182,906 Direct | -3.81% | Disposed | (price as of 2026-10-05) |
| Aug. 2, 2022 | MCFT | A | 30,786 | · | · | 165,485 Direct | +22.86% | Acquired | (price as of 2026-10-05) |
| July 27, 2021 | MCFT | A | 20,162 | · | · | 134,699 Direct | +17.60% | Acquired | (price as of 2026-10-05) |
| Dec. 2, 2020 | MCFT | F | 3,043 | $21.93 | $66,733 | 114,537 Direct | -2.59% | Disposed | -9.7% (price as of 2026-10-05) |
| July 16, 2020 | MCFT | A | 26,316 | · | · | 117,580 Direct | +28.84% | Acquired | (price as of 2026-10-05) |
| Dec. 2, 2019 | MCFT | A | 18,563 | · | · | 91,264 Direct | +25.53% | Acquired | (price as of 2026-10-05) |
| Dec. 2, 2019 | MCFT | A | 25,000 | · | · | 72,701 Direct | +52.41% | Acquired | (price as of 2026-10-05) |
| Oct. 30, 2019 | MCFT | A | 15,000 | · | · | 47,701 Direct | +45.87% | Acquired | (price as of 2026-10-05) |
| July 18, 2019 | MCFT | A | 3,378 | · | · | 32,701 Direct | +11.52% | Acquired | (price as of 2026-10-05) |
| June 7, 2019 | MCFT | S | 5,000 | $20.84 | $104,200 | 29,323 Direct | -14.57% | Disposed | -4.9% (price as of 2026-10-05) |
| July 19, 2018 | MCFT | A | 2,069 | · | · | 34,323 Direct | +6.41% | Acquired | (price as of 2026-10-05) |
| July 20, 2017 | MCFT | A | 2,844 | · | · | 32,254 Direct | +9.67% | Acquired | (price as of 2026-10-05) |
| Aug. 25, 2016 | MCFT | A | 4,641 | · | · | 29,410 Direct | +18.74% | Acquired | (price as of 2026-10-05) |
| April 22, 2016 | MCFT | A | 2,040 | · | · | 24,769 Direct | +8.98% | Acquired | (price as of 2026-10-05) |
| July 24, 2015 | MCFT | A | 22,729 | · | · | 22,729 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 24, 2015 | MCFT | Restricted Stock Unit | Common Stock | · | · | 22,729 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $700,000 | · | $1,373,637 | · | $1,118,425 | · | $16,604 | $3,208,666 |
| 2020 | $456,923 | · | $606,986 | · | $104,216 | · | $18,177 | $1,186,302 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.